Delcath Has A Path To Profitability
Delcath Systems (DCTH) is a hybrid medical device company that treats primary and metastatic liver cancer. It is very common for primary cancer from other body organs to metastasize in the liver as the liver filters out harmful substances in the blood.
The FDA cleared the company's Hepzato Kit in August 2023 for treating metastatic ocular melanoma ("mOM"…
Keep reading with a 7-day free trial
Subscribe to Microcap Opportunities to keep reading this post and get 7 days of free access to the full post archives.